Roy S. Herbst, MD, PhD | Authors

OGDEN CLINIC

4650 HARRISON BLVD

Articles

Roy S. Herbst, MD, PhD, Discusses ADAURA Trial and Future of Lung Cancer Treatment

June 12, 2020

Roy S. Herbst, MD, PhD, of the Yale Cancer Center discussed the future of lung cancer treatment to follow the phase III ADAURA trial regarding osimertinib as adjuvant therapy to treat NSCLC presented at the 2020 ASCO Virtual Scientific Program.

Roy S. Herbst, MD, PhD, Talks Key Takeaway from Phase III ADAURA Trial

June 03, 2020

Roy S. Herbst, MD, PhD, of the Yale Cancer Center discussed his key takeaway from the phase III ADAURA trial regarding osimertinib as adjuvant therapy to treat NSCLC presented at the 2020 ASCO Virtual Scientific Program.